Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1989 Sep;48(9):790–791. doi: 10.1136/ard.48.9.790

Evaluating drugs in rheumatoid arthritis.

A Larsen
PMCID: PMC1003879  PMID: 2802806

Full text

PDF
790

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borg G., Allander E., Lund B., Berg E., Brodin U., Pettersson H., Trang L. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. J Rheumatol. 1988 Dec;15(12):1747–1754. [PubMed] [Google Scholar]
  2. McConkey B., Crockson R. A., Crockson A. P., Wilkinson A. R. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med. 1973 Oct;42(168):785–791. [PubMed] [Google Scholar]
  3. Nordstrom D. M., West S. G., Andersen P. A., Sharp J. T. Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med. 1987 Dec;107(6):797–801. doi: 10.7326/0003-4819-107-6-797. [DOI] [PubMed] [Google Scholar]
  4. Scott D. L., Spector T. D., Pullar T., McConkey B. What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis. 1989 Mar;48(3):256–261. doi: 10.1136/ard.48.3.256. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES